Device Trial Radar · NCT00731640
Contralateral ReSTOR / Monofocal or Phakic Eye
Last checked: Nov 20, 2026Latest source record: Mar 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Jun 2007
Primary completion
May 2008
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Bilateral evaluation of unilateral implantation of ReSTOR and contralateral monofocal or phakic eye.
Conditions
- Cataracts
Interventions
ReSTORDevice
AcrySof ReSTOR +4 Intraocular Lens (IOL) unilaterally implanted
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual AcuityTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Alcon Call Center for Trial Locations
Fort Worth, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.